Suvretta Capital Management, Llc - Nov 19, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Nov 19, 2024
Transactions value $
$416,616
Form type
4
Date filed
11/21/2024, 04:24 PM
Previous filing
Sep 30, 2024
Next filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $121K +12.4K +0.16% $9.73 7.9M Nov 19, 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $15.3K +1.57K +0.17% $9.73 947K Nov 19, 2024 See footnotes F1, F3
transaction BNTC Common stock, par value $0.0001 per share Purchase $249K +24.4K +0.31% $10.22 7.92M Nov 20, 2024 See footnotes F1, F4
transaction BNTC Common stock, par value $0.0001 per share Purchase $31.4K +3.08K +0.32% $10.22 950K Nov 20, 2024 See footnotes F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.
F4 Notes are included on Exhibit 99.1.
F5 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature